GENE ONLINE|News &
Opinion
Blog

LATEST
BioMarin’s Dwarfism Drug Garners FDA Nod Amidst Concerns Over Threat to Dwarf Pride
2021-11-21
New Research on Neoantigens and Tumor-targeting T-cells Marks Paradigm Shift in Countering Solid Tumors
2021-11-19
Shionogi and Ildong Team up to Co-Develop Oral COVID-19 Pill
2021-11-19
Merck’s Keytruda Bags FDA Approval for Early Kidney Cancer in Adjuvant Setting
2021-11-18
Brigham and Women’s Hospital Initiates First Clinical Trial of Nasal Vaccine for Alzheimer’s Disease
2021-11-18
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
Chroma Medicine Debuts with High Hopes for “Game-Changing” Epigenetic Genome Editors
2021-11-17
SK Bioscience Files for Approval of Novavax’s COVID-19 Vaccine
2021-11-17
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
How is China Driving Global Progress in Innovation and Access? – A Discussion with BeiGene CEO John Oyler
2021-11-16
Canadian Regulators Give Go-Ahead for Diabetes Trial Using CRISPR, ViaCyte’s Gene-Edited Stem Cell-Derived Therapy
2021-11-16
Moderna, AstraZeneca Tout Encouraging Trial Data for mRNA-Based Therapeutic in Cardiac Health
2021-11-16
9 Leading Molecular Diagnostics Companies to Watch in Taiwan
2021-11-15
FDA Approves First Interferon Therapy for Rare Blood Cancer
2021-11-15
Boston-Based Cancer Immunotherapy Startup Secures $45 Million in Series B
2021-11-15
1 108 109 110 111 112 218
EVENT
Scroll to Top